A Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain
A Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain
Recruiting · NCT06596681 · Registry updated 2026-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain | Intractable Pain, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nervous system disorder, neuralgia, neuromuscular disease, peripheral nervous system disorder | Recruiting | Early phase 1 | 2026-07-31 | NCT06596681 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Tiantan Hospital | 307 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Tiantan Hospital | Beijing | China | 62 |